Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1571414

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571414

Duodenal Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Duodenal Ulcer Treatment Market Growth & Trends:

The global duodenal ulcer treatment market size is anticipated to reach USD 5.54 billion by 2030, growing at a CAGR of 3.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of elements focused on the management and treatment of duodenal ulcers, which are sores that occur in the lining of the duodenum.

Pharmacological treatments are crucial to the duodenal ulcer treatment market. These medications include proton pump inhibitors (PPIs), histamine receptor antagonists (H2RAs), and antibiotics targeting Helicobacter pylori infections, mucosal protectants, and antacids. These medications reduce gastric acid production, eradicate bacterial pathogens, enhance mucosal defense, or neutralize stomach acid. This therapeutic approach alleviates bloating, abdominal pain, and discomfort while accelerating ulcer healing.

The market is experiencing significant growth due to the incorporation of digital health solutions such as mobile apps, telemedicine platforms, and remote monitoring tools. These technologies enable personalized treatment management, real-time symptom tracking, and enhanced patient engagement. Additionally, artificial intelligence (AI) algorithms are being employed to analyze large datasets, which improves treatment outcomes and facilitates early detection of ulcer issues.

Duodenal Ulcer Treatment Market Report Highlights:

  • Based on treatment, the proton pump inhibitors dominated the market with the largest revenue share of 52.3% in 2023 due to their superior effectiveness in managing and healing duodenal ulcers.The widespread use of PPIs is driven by their favorable safety profile and high tolerability. They are available in various formulations, including extended-release options, which enhance patient compliance and convenience.
  • Based on route of administration, the oral segment dominated the market with the largest revenue share of 78.44% in 2023. Oral formulations are generally more cost-effective than injectable or intravenous options, contributing to their widespread use. Their extensive market presence and proven efficacy reinforce their leading revenue share in the treatment market.
  • Based on distribution channel, the retail pharmacies segment dominated the market with the largest revenue share of 57.45% in 2023. Retail pharmacies offer patients immediate access to medications without needing hospital or specialist visits, enhancing convenience and adherence. Their established distribution networks and customer service also facilitate efficient medication management and refill processes, further driving revenue in this channel.
  • Based on region, the North America region dominated the market with a significant share of 39.54% in 2023. This is driven by continuous innovation and extensive healthcare infrastructure. Innovations include the development of novel drug formulations and delivery systems aimed at improving patient compliance and treatment efficacy.
Product Code: GVR-4-68040-446-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Outlook
    • 2.2.2. Route of Administration Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Duodenal Ulcer Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of duodenal ulcers
      • 3.2.1.2. Advancements in treatment options
      • 3.2.1.3. Growing awareness and education about gastrointestinal health
      • 3.2.1.4. Growing geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High treatment costs
      • 3.2.2.2. Low reimbursement policies
  • 3.3. Duodenal Ulcer Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Duodenal Ulcer Treatment Market: Treatments Estimates & Trend Analysis

  • 4.1. Global Duodenal Ulcer Treatment Market: Treatments Dashboard
  • 4.2. Global Duodenal Ulcer Treatment Market: Treatments Movement Analysis
  • 4.3. Global Duodenal Ulcer Treatment Market by Treatments, Revenue
  • 4.4. Proton Pump Inhibitors
    • 4.4.1. Proton pump inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. H2 Antagonists
    • 4.5.1. H2 Antagonists market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Antibiotics
    • 4.6.1. Antibiotics market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other
    • 4.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Duodenal Ulcer Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Global Duodenal Ulcer Treatment Market: Route of Administration Dashboard
  • 5.2. Global Duodenal Ulcer Treatment Market: Route of Administration Movement Analysis
  • 5.3. Global Duodenal Ulcer Treatment Market Estimates and Forecasts, By Route of Administration, Revenue (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Parenteral
    • 5.5.1. Parenteral market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Duodenal Ulcer Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Duodenal Ulcer Treatment Market: Distribution Channel Dashboard
  • 6.2. Global Duodenal Ulcer Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Duodenal Ulcer Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hospital Pharmacies
    • 6.5.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Duodenal Ulcer Treatment Market: Regional Estimates & Trend Analysis by Treatments, Route of Administration, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. GSK plc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Pfizer
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Abbott
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck KGaA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. NIHON GENERIC Co., Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Bristol-Myers Squibb Company
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. AstraZeneca
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Takeda Pharmaceutical Company Limited
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Eisai Co., Ltd.
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
Product Code: GVR-4-68040-446-2

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Duodenal ulcer treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 North America Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 North America Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7 U.S. Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 8 U.S. Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Canada Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 11 Canada Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Mexico Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 14 Mexico Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Duodenal ulcer treatment market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Europe Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 18 Europe Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Germany Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Germany Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 UK Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 UK Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 24 UK Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 France Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 France Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 27 France Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Italy Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Italy Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Spain Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 Spain Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35 Denmark Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Sweden Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Norway Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41 Norway Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Duodenal ulcer treatment market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 China Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 China Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 49 China Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Japan Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 India Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 India Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 55 India Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 57 South Korea Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 Australia Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Thailand Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63 Thailand Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Latin America Duodenal ulcer treatment market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 Latin America Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Brazil Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 70 Brazil Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 73 Argentina Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 74 Argentina Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Duodenal ulcer treatment market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 MEA Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78 MEA Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 80 South Africa Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 81 South Africa Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 86 UAE Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 87 UAE Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Duodenal ulcer treatment market: market outlook
  • Fig. 7 Duodenal ulcer treatment competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Duodenal ulcer treatment market driver impact
  • Fig. 11 Duodenal ulcer treatment market restraint impact
  • Fig. 12 Duodenal ulcer treatment market: Treatment movement analysis
  • Fig. 13 Duodenal ulcer treatment market: Treatment outlook and key takeaways
  • Fig. 14 Proton Pump Inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 H2 Antagonists market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Duodenal ulcer treatment market: Route of Administration movement analysis
  • Fig. 19 Duodenal ulcer treatment market: Route of Administration outlook and key takeaways
  • Fig. 20 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Duodenal ulcer treatment market: Distribution Channel movement analysis
  • Fig. 23 Duodenal ulcer treatment market: Distribution Channel outlook and key takeaways
  • Fig. 24 Retail Pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Hospital Pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global duodenal ulcer treatment market: Regional movement analysis
  • Fig. 28 Global duodenal ulcer treatment market: Regional outlook and key takeaways
  • Fig. 29 Global duodenal ulcer treatment market share and leading players
  • Fig. 30 North America, by country
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. key country dynamics
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada key country dynamics
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico key country dynamics
  • Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK key country dynamics
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany key country dynamics
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 France key country dynamics
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy key country dynamics
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain key country dynamics
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark key country dynamics
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden key country dynamics
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway key country dynamics
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China key country dynamics
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India key country dynamics
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand key country dynamics
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea key country dynamics
  • Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil key country dynamics
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina key country dynamics
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa key country dynamics
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia key country dynamics
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 UAE key country dynamics
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait key country dynamics
  • Fig. 81 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Market share of key market players- Duodenal ulcer treatment market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!